The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...